Zengxue Wang

Title: Zengxue Wang: Innovator in Pharmaceutical Synthesis

Introduction

Zengxue Wang is a notable inventor based in Linyi, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important drug intermediates. His work is characterized by innovative methods that enhance the efficiency of drug production.

Latest Patents

Wang holds a patent for a synthetic method for montelukast sodium intermediate. This patent describes a synthesis method for preparing the Montelukast sodium intermediate 2-(2-(3-(2-(7-chloro-2-quinolyl)vinyl)phenyl-3-oxopropyl)phenyl)propanol. The method involves condensing the starting materials 7-chloroquinaldine and 3-cyanobenzaldehyde, followed by a reaction with 2-(2-ortho-(2-haloethyl)-phenylpropyl)tetrahydropyrane ether. This innovative approach allows for the easy acquisition of starting materials and is suitable for mass production.

Career Highlights

Zengxue Wang is associated with Shandong New Time Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical synthesis. His work has contributed to advancements in the production of essential medications, showcasing his commitment to improving healthcare through innovation.

Collaborations

Wang collaborates with talented colleagues, including Zhiquan Zhao and Haixin Wang. Their combined efforts in research and development have led to significant advancements in pharmaceutical synthesis.

Conclusion

Zengxue Wang is a prominent figure in the field of pharmaceutical innovation, with a focus on efficient synthesis methods. His contributions are vital for the advancement of drug production, and his work continues to impact the pharmaceutical industry positively.